Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-025881

Director sold 25,000 shares at $29.77 ($744,250)

  • Director acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HERSHBERG ROBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-23 Exercise or conversion : show line 1 in the form +25,000 $0.45 $11,250 25,000 D
2020-04-23 Sale : show line 2 in the form −25,000 $29.77 $744,250 0 D
Open-market sales · 25,000 sh · avg $29.77 · $744,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-04-23 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −25,000 75,000 D
Loading xslF345X03/doc4.xml…